Toxicokinetics of a dipyridamole (Persantin) intoxication: Case report

Human and Experimental Toxicology

Volumn 30, Issue 1, 2011, Pages 74-78

  Lagas, Jurjen S ^a   Wilhelm, Abraham J ^b   Vos, René M ^b   Van Den Dool, Erik Jan ^c   Van Der Heide, Yvonne ^a   Huissoon, Sandra ^a   Beijnen, Jos H ^a,d   Brandjes, Desiderius P M ^a  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

clinical toxicology; poisonings; toxicodynamics; toxicokinetics

Indexed keywords

ACTIVATED CARBON; AMINOPHYLLINE; DIPYRIDAMOLE; MAGNESIUM SULFATE; OXAZEPAM; TEMAZEPAM;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; DRUG BLOOD LEVEL; DRUG INTOXICATION; ELECTROCARDIOGRAPHY; ENTEROHEPATIC CIRCULATION; FEMALE; HUMAN; PRIORITY JOURNAL; SOMNOLENCE; SUICIDAL IDEATION; THORAX PAIN; THROMBOCYTE ACTIVATION; TOXICOKINETICS;

ANTI-ANXIETY AGENTS; DIPYRIDAMOLE; FEMALE; HUMANS; MIDDLE AGED; OXAZEPAM; PLATELET AGGREGATION INHIBITORS; SUICIDE, ATTEMPTED; TEMAZEPAM;

EID: 78650189103     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110368696     Document Type: Article

References (13)

1. Halkes PH, van Gijn J., Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006 ; 367: 1665-1673.
2. Miura M., Tominaga S., Hashimoto K. Potentiation of reactive hyperemia in the coronary and femoral circulation by the selective use of 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimodo[5,4-d]pyrimidine. Arzneimittelforschung 1967 ; 17: 976-979.
3. Beller GA Pharmacologic stress imaging. JAMA 1991 ; 265: 633-638.
4. Hojer J., Baehrendtz S., Gustafsson L. Benzodiazepine poisoning: experience of 702 admissions to an intensive care unit during a 14-year period. J Intern Med 1989 ; 226: 117-122.
5. Gaudreault P., Guay J., Thivierge RL, Verdy I. Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment. Drug Saf 1991 ; 6: 247-265.
6. Moffat AC, Osselton MD, Widdop B. Clarke's analysis of drugs and poisons. 3 rd ed. London: Pharmaceutical Press, 2009.
7. Brinson K. Effect of aminophylline on blood platelet reactions. Atherosclerosis 1972 ; 16: 233-239.
8. Vinge E., Andersson KE, Persson CG Effects on aggregation of human platelets of two xanthines and their interactions with adenosine. Acta Physiol Scand 1984 ; 120: 117-121.
9. Misso NL, Thompson PJ Xanthines inhibit human platelet aggregation induced by platelet-activating factor. Clin Exp Pharmacol Physiol 1992 ; 19: 599-602.
10. Jahangiri M., Holdright DR Myocardial infarction secondary to dipyridamole overdose. Arch Emerg Med 1992 ; 9: 62-64.
11. Chen ZC, Kwan CM, Chen JH Profound shock resulting from a large dose of dipyridamole. Int J Cardiol 1994 ; 46: 75-78.
12. Personne M., Mansten A., Svensson JO A case report. Unconscious patient with neon yellow skin was intoxicated with dipyridamole. Lakartidningen 2003 ; 100: 4194-4195.
13. Gregov D., Jenkins A., Duncan E., Siebert D., Rodgers S., Duncan B., et al. Dipyridamole: pharmacokinetics and effects on aspects of platelet function in man. Br J Clin Pharmacol 1987 ; 24: 425-434.